Factors affecting recombinant Adeno-Associated Virus titers during triple-plasmid transient transfection in HEK-293 cells

Author:

Pistek Martina1,Andorfer Peter1,Grabherr Reingard2,Kraus Barbara1,Bort Juan A. Hernandez1ORCID

Affiliation:

1. Gene Therapy Process Development, Baxalta Innovations GmbH, a part of Takeda companies, Uferstraße 15, A-2304 Orth an der Donau, Austria

2. Biotechnology Department, University of Natural Resources and Life Sciences, , Muthgasse 18. A-1190, Vienna, Austria

Abstract

Abstract The efficiency of triple-plasmid transfection in recombinant Adeno-Associated Virus (rAAV) production was analyzed by examining two distinct strains of HEK-293 cells. These strains were categorized as high producer (HP) and low producer (LP) based on their differing levels of productivity under identical conditions. Analysis of RNA expression levels of viral genes revealed disparities in plasmid derived gene expression between the cell lines. Further assessment of transfection efficacy utilizing labeled plasmids revealed lower plasmid uptake and less efficient nuclear transport in LP cell line. Additionally, we observed inferior translation activity in LP, contributing to its shortcomings in overall productivity. In our attempt to optimize plasmid ratios to enhanced fully packaged rAAV particle yield, we discovered cell-strain-specific optimization potential. The findings highlight the transfection's complexity, urging tailored strategies for improved rAAV production based on each cell line's characteristics, enhancing understanding and guiding further efficiency optimization in rAAV production.

Publisher

Research Square Platform LLC

Reference43 articles.

1. Effect of the Compaction and the Size of DNA on the Nuclear Transfer Efficiency after Microinjection;Akita H;Synchronized Cells Pharm,2015

2. Viral vector platforms within the gene therapy landscape;Bulcha JT;Signal Transduct Target Therapy,2021

3. Human cell lines for biopharmaceutical manufacturing: history, status, and future perspectives;Dumont J;Crit Rev Biotechnol,2016

4. Expression systems for therapeutic glycoprotein production;Durocher Y;Curr Opin Biotechnol,2009

5. Scalable serum-free production of recombinant adeno-associated virus type 2 by transfection of 293 suspension cells;Durocher Y;J Virol Methods,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3